Correction: KEAP1-NRF2 signalling and autophagy in protection against oxidative and reductive proteotoxicity.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

3 citing papers in PubMed.

1. Evaluation of Antioxidant Effects of Coenzyme Q10 against Hyperglycemia-Mediated Oxidative Stress by Focusing on Nrf2/Keap1/HO-1 Signaling Pathway in the Liver of Diabetic Rats.Iranian journal of medical sciences · 2024
   Article
2. Survival of the fittest: how myeloid-derived suppressor cells survive in the inhospitable tumor microenvironment.Cancer immunology, immunotherapy : CII · 2020
   Review
3. Constitutive activation of Nrf2 induces a stable reductive state in the mouse myocardium.Redox biology · 2017
   Article

Corrections and comments

• Erratum for
  KEAP1-NRF2 signalling and autophagy in protection against oxidative and reductive proteotoxicity.2015

Authors and funding

5 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.